There are currently no generic Ortho Tri-Cyclen Lo products available on the market. A generic version was briefly launched by Teva Pharmaceutical Industries, but due to a lawsuit, the company was forced to stop selling it. At this time, the earliest predictable date that a generic could become available is December 31, 2015.
Ortho Tri-Cyclen Lo is made by Janssen Pharmaceuticals, Inc. It is currently under the protection of patents that prevent any generic Ortho Tri-Cyclen Lo from being manufactured in the United States.
When Will Generic Ortho Tri-Cyclen Lo Be Available?
Teva Pharmaceutical Industries briefly launched a generic version of this medication (sold under the name Tri-Lo Sprintec™) but was forced to stop selling this product during a lawsuit. Teva and Janssen have settled the lawsuit which will allow Teva to beginning selling Tri-Lo Sprintec On December 31, 2015. At this time, this is the earliest predictable date that a generic could become available. Janssen and Watson Pharmaceuticals have a similar agreement as well, which will allow Watson to sell a generic version on the same date.
Will My Insurance Cover Ortho Tri-Cyclen Lo?
Each insurance company is different. There has been a long history of insurance companies not covering contraceptive products, although this is beginning to change. Because Ortho Tri-Cyclen Lo is not available in a generic form, you may have to pay a higher copayment if your insurance company covers it.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Watson Pharmaceuticals. Watson reaches settlement with Janssen Pharmaceuticals, Inc. over Ortho Tri-Cyclen Lo (2/8/2012). Watson Web site. Available at: http://ir.watson.com/phoenix.zhtml?c=65778&p=irol-newsArticle&ID=1658345&highlight=. Accessed April 19, 2012.
Teva Pharmaceutical Industries. Teva And Ortho-McNeil-Janssen settle Ortho Tri-Cyclen® Lo litigation (7/24/2009). Available at: http://www.tevapharm.com/pr/2009/pr_862.asp. Accessed October 23, 2009.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed December 21, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click